ALK-rearranged adenosquamous lung cancer presenting as squamous cell carcinoma: A potential challenge to histologic type triaging of nsclc biopsies for molecular studies

Clinical Lung Cancer

Volumn 15, Issue 3, 2014, Pages

  Dragnev, Konstantin H ^a   Gehr, Gerald ^a   Memoli, Vincent A ^b   Tafe, Laura J ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Adenosquamous carcinoma; ALK FISH; ALK rearrangement; Molecular testing; Non small cell lung cancer

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; FLUORODEOXYGLUCOSE F 18; PROTEIN TYROSINE KINASE;

ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CANCER PATIENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EMERGENCY HEALTH SERVICE; FINE NEEDLE ASPIRATION BIOPSY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LUNG ADENOSQUAMOUS CARCINOMA; LUNG CARCINOMA; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUBERCULOSIS; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MOLECULAR GENETICS; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; SOMATIC MUTATION; THORAX RADIOGRAPHY; THORAX SURGERY; TUMOR VOLUME; BIOPSY; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; GENETICS; LUNG NEOPLASMS; NON SMALL CELL LUNG CANCER; PATHOLOGY; PRACTICE GUIDELINE; PROCEDURES;

BIOPSY; BIOPSY, FINE-NEEDLE; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; GENE REARRANGEMENT; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84898712464     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2014.01.003     Document Type: Article

References (18)

1. D.W. Wong, E.L. Leung, and K.K. So et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS Cancer 115 2009 1723 1733
2. N.I. Lindeman, P.T. Cagle, and M.B. Beasley et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology J Thorac Oncol 8 2013 823 859
3. N. Rekhtman, S.M. Brandt, and C.S. Sigel et al. Suitability of thoracic cytology for new therapeutic paradigms in non-small-cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing J Thorac Oncol 6 2011 451 458
4. W.D. Travis, N. Rekhtman, and G.J. Riley et al. Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift J Thorac Oncol 5 2010 411 414
5. J.A. Bishop, J. Teruya-Feldstein, W.H. Westra, G. Pelosi, W.D. Travis, and N. Rekhtman p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma Mod Pathol 25 2012 405 415
6. W.D. Travis, E. Brambilla, and H.K. Muller-Hermelink et al. WHO Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart 2004 IARC Press Lyon, France
7. N. Tochigi, S. Dacic, M. Nikiforova, K.M. Cieply, and S.A. Yousem Adenosquamous carcinoma of the lung: a microdissection study of KRAS and EGFR mutational and amplification status in a Western patient population Am J Clin Pathol 135 2011 783 789
8. A. Yoshida, K. Tsuta, and H. Nakamura et al. Comprehensive histologic analysis of ALK-rearranged lung carcinomas Am J Surg Pathol 35 2011 1226 1234
9. H. Uramoto, S. Yamada, and T. Hanagiri Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: risk of coexistent double cancer J Cardiothorac Surg 5 2010 92
10. S. Takamori, M. Noguchi, and S. Morinaga et al. Clinicopathologic characteristics of adenosquamous carcinoma of the lung Cancer 67 1991 649 654
11. M. Nishino, V.E. Klepeis, and B.Y. Yeap et al. Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas Mod Pathol 25 2012 1462 1472
12. N. Ochi, H. Yamane, T. Yamagishi, N. Takigawa, and Y. Monobe Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene? Lung Cancer 79 2013 94 95
13. D. Alrifai, S. Popat, and M. Ahmed et al. A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations Lung Cancer 80 2013 339 340
14. H. Kim, E. Park, Y.J. Kim, and J.H. Chung ALK rearrangement in a pure squamous cell carcinoma: the challenge of detection of ALK rearrangement Virchows Arch 462 2013 597 599
15. N. Rekhtman, P.K. Paik, and M.E. Arcila et al. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations Clin Cancer Res 18 2012 1167 1176
16. J.E. Chaft, N. Rekhtman, M. Ladanyi, and G.J. Riely ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinoma J Thorac Oncol 7 2012 768 769
17. A. Drilon, N. Rekhtman, M. Ladanyi, and P. Paik Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy Lancet Oncol 13 2012 e418 e426
18. K. Mantripragada, and H. Khurshid Targeting genomic alterations in squamous cell lung cancer Front Oncol 3 2013 195